- Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin2021 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Inhibition of activator protein 1 signaling abrogates transforming growth factor beta-mediated activation of fibroblasts and prevents experimental fibrosis2012 | First Faculty of Medicine
- The Nuclear Receptor Constitutive Androstane Receptor/NR1I3 Enhances the Profibrotic Effects of Transforming Growth Factor beta and Contributes to the Development of Experimental Dermal Fibrosis2014 | First Faculty of Medicine
- Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis2012 | First Faculty of Medicine
- Inactivation of the Transcription Factor STAT-4 Prevents Inflammation-Driven Fibrosis in Animal Models of Systemic Sclerosis2011 | First Faculty of Medicine
- Inactivation of the Cannabinoid Receptor CB1 Prevents Leukocyte Infiltration and Experimental Fibrosis2010 | First Faculty of Medicine
- Vitamin D receptor regulates TGF-beta signalling in systemic sclerosis2015 | First Faculty of Medicine
- Tribbles homologue 3 stimulates canonical TGF-beta signalling to regulate fibroblast activation and tissue fibrosis2016 | First Faculty of Medicine
- S100A4 amplifies TGF-beta-induced fibroblast activation in systemic sclerosis2015 | First Faculty of Medicine
- Sirt1 regulates canonical TGF-beta signalling to control fibroblast activation and tissue fibrosis2016 | First Faculty of Medicine
- S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin2023 | First Faculty of Medicine, Faculty of Physical Education and Sport